Loading…

Lipoxygenase in Condition of Experimental Hypertriacylglycerolaemia

Animal lipoxygenases (EC 1.13.11.12, LOX) convert arachidonic acid to biological active compounds known as eicosanoids. Proinflammatory eicosanoids - leukotrienes are involved in progression of atherosclerosis. Our attention was focused on a connection between activity of LOX and primary hypertriacy...

Full description

Saved in:
Bibliographic Details
Published in:Acta Facultatis Pharmaceuticae Universitatis Comenianae 2013-06, Vol.LX (1), p.21-25
Main Authors: Kováčiková, Veronika, Obložinský, Marek, Kollárová, Renáta, Bezáková, Lýdia, Šišková, Katarína, Pauliková, Ingrid
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Animal lipoxygenases (EC 1.13.11.12, LOX) convert arachidonic acid to biological active compounds known as eicosanoids. Proinflammatory eicosanoids - leukotrienes are involved in progression of atherosclerosis. Our attention was focused on a connection between activity of LOX and primary hypertriacylglycerolaemia, untreated or treated with fenofibrate. Our results show that LOX activity in the cytoplasm derived from liver of hypertriacylglycerolaemic rats is significantly increased (pH 7,2; relative to the control group), which may be one reason for more rapid atherosclerosis progression in lipid metabolism disorders. The highest LOX activity in microsomes was showed in groups of rats treated with fenofibrate. It appears that fibrates indirectly promote association of LOXs to membranes. In fat fraction no significant effect of hypertriacylglycerolaemia on the activity of lipoxygenase was found. Using gel electrophoresis significantly different spectrum of proteins was discovered in the control samples and samples of hypertriacylglycerolaemic rats. It appears that in condition of lipid metabolism imbalance formation of proteins with low molecular weight (and possibly also expression of LOX) is elevated.
ISSN:0301-2298
1338-6786
2453-6725
DOI:10.2478/afpuc-2013-0011